Sleep in patients with treated Wilson's disease. A questionnaire study

Nordic Journal of Psychiatry

Volumn 56, Issue 4, 2002, Pages 291-297

  Portala, Kamilla ^a   Westermark, Kerstin ^a   Ekselius, Lisa ^a   Broman, Jan Erik ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hepatolenticular degeneration; Sleep; Sleep paralysis; Wilson's disease

Indexed keywords

FLUPENTIXOL; NEFAZODONE; PENICILLAMINE; PSYCHOTROPIC AGENT; TRIENTINE; VENLAFAXINE; ZINC ACETATE;

ADULT; AGED; AROUSAL; ARTICLE; CATAPLEXY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; FATIGUE; FEMALE; HEART PALPITATION; HUMAN; LIFESTYLE; MALE; NIGHT SLEEP; NIGHTMARE; PARASOMNIA; QUESTIONNAIRE; REM SLEEP; REST; SLEEP; SLEEP DISORDER; SLEEP PATTERN; SLEEP TIME; STANDARDIZATION; SYMPTOM; WILSON DISEASE;

ADULT; CASE-CONTROL STUDIES; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SEX FACTORS; SLEEP; SLEEP DISORDERS;

EID: 0036392675     PISSN: 08039488     EISSN: None     Source Type: Journal    
DOI: 10.1080/08039480260242796     Document Type: Article

References (36)

1. Scheinberg IH, Sternlieb I. Wilson's disease. In: Smith LH JR, editor. Major Problems in Internal Medicine, Vol XXIII. Philadelphia: WB Saunders Co; 1984.
2. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type APTase similar to the Menkes gene. Nat Genet 1993;5:327-37.
3. Petrukhin K, Lutsenko S, Chernov I, Ross BM, Kaplan JH, Gilliam TC. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organiznation, alternative splicing, and structure/function predictions. Hum Mol Genet 1994;3:1647-56.
4. Gollan JL, Gollan TJ. Wilson's disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998;28(Suppl 1):28-36.
5. Dening TR, Berrios GE. Wilson's disease: clinical groups in 400 cases. Acta Neurol Scand 1989;80:527-34.
6. Dening TR, Berrios GB. Wilson's Disease: a prospective study of psychopathology in 31 cases. Br J Psychiatry 1989;155:206-13.
7. Borijigin J, Payne AS, Deng J, Li X, Wang MM, Ovodenko B, Gitlin JD, Synder SH. A novel pineal night-specific ATPase encoded by the Wilson Disease gene. J Neurosci 1999;19:1018-26
8. Barkhatova VP, Larsky G, Markova E, Ivanova-Smolenskaya IA, Demina EG. Changes in concentration of catecholamines in striatum of patients with hepatolenticular degeneration. In: Czlonkowska A, Van den Haner CJA, editors. Proceeding of the 5th Symposium on Wilson's Disease. Delft: Technical University; 1995. p. 165-73.
9. Nyberg P, Gottfries C-G, Holmgren G, Persson S, Roos B-E, Winblad B. Advanced catecholaminergic disturbances in the brain in a case of Wilson's disease. Acta Neurol Scand 1982;65:71-5.
10. Kish S, Dozik S, Deck J, Shannak K, Hornykiewicz O. Brain adrenergic changes in a patient with Wilson's disease. J Neuropat Exp Neurol 1990;49:280.
11. Nijeholt JL, Korf J. Wilson's disease and monoamines. Arch Neuro 1978;35:617.
12. Snow BJ, Bhatt M, Martin WRW, Li D, Caine DB. The nitrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography. J Neurol Neurosurg Psychiatry 1991;54:12-7.
13. 113I]β-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease. J Neurol Neurosurg Psychiatry 1998;65:60-4.
14. Oertel WH, Tatsch K, Schwartz J, Kraf E, Trenkwalder C, Scherer J, et al. Decrease of D2 receptors indicated by 123 I-Iodobenzamide single-photon emisson computed tomography relates to neurological deficit in treated Wilson's disease. Ann Neurol 1992;32:743-8.
15. Westermark K, Tedroff J, Thuomas K-Å, Hartvig P, Långström B, Andersson Y, et al. Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers. Mov Disord 1995;10:596-603.
16. Hawkins RA, Mazziotta JC, Phelps ME. Wilson's disease studied with FDG and positron emission tomography. Neurology 1987;37:1707-11.
17. Kirkham T, Kamin DF. Slow saccadic eye movements in Wilson's disease. J Nerv Ment Dis 1956;124:251-5.
18. Berardelli A, Inghilleri M, Priori A, Thompson PD, Fabri S, Fieschi C, Manfredi M. Involvement of corticospinal tract in Wilson's disease. Mov Disord 199;5:334-7.
19. Chu NS. Sensory evoked potentials in Wilson's disease. Brain 1986; 109:491-507.
20. Grimm G, Madl C, Katzenschlager R, Oder W, Ferenci P. Gangl A. Detailed evaluation of evoked potentials in Wilson's disease. Electroenceph clin Neurophysiol 1992;82:119-24.
21. Janson C, Gislason T, Boman G, Hetta J, Roos BE. Sleep disturbance in patients with asthma. Respir Med 1990;84:37-42.
22. Elmasry A, Lindberg E, Berne C, Janson C, Gislason T. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001;249:153-61.
23. Gudbjörnsson B, Broman J-E, Hetta J, Hällgren R. Sleep disturbances in patients with primary Sjögren's syndrome. B J Rheumatology 1993;32:1072-6.
24. Hultgren S, Broman J-E, Gudbjörnsson B, Hetta J, Lindqvist U. Sleep disturbances in outpatients with ankylosing spondylitis, a questionnaire study with gender implications. Scand J Rheumatol 2000;29:365-9.
25. Edéll-Gustafsson U. Sleep, psychological symptoms and quality of life in patients undergoing coronary artery bypass grafting. Thesis, Linköping University; 1999.
26. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorder: meta-analysis. Arch Gen Psychiatry 1992-49:651-68.
27. Portala K, Westermark K, Knorring Lv, Ekselius L. Psycho-pathology in treated Wilson's disease determined by means of CPRS expert and self-ratings. Acta Psychiatr Scand 2000;101:104-9.
28. Firneisz G, Szalay F, Halasz P, Komoly S. Hypersomnia in Wilson's disease: an unusual symptom in an unusual case. Acta Neurol Scand 2000;101:286-8.
29. McCarley RW, Greene RW, Rainnie D, et al. Brain stem neuromodulation and REM sleep. Semin Neurosci 1995;7:341-54.
30. Waldenström E, Lagerkvist A, Dahlman T, Westermark K, Landegren U. Efficient detection of mutations in Wilson disease by manifold sequencing. Genomics 1996;37:303-9.
31. Hetta J, Mallon L, Bengtsson H, Smedje H, Beoman J-E. Polysomnographic versus questionnaire data on difficulties falling asleep ad total night sleep (abstract). J Sleep Res 1998;7(Suppl 2):16.
32. Hetta J, Almqvist M, Ågren H, Hambert G, Liljeberg B, Roos B-E. Prevalence of sleep disturbances and related symptoms in middle-aged Swedish population. In: WP Koella, E Ruther, H Schulz, editors. Sleep '84. Stuttgart: Gustav Fischer Verlag; 1985. p. 373-6.
33. Broman J-E, Lundh L-G, Hetta J. Insufficient sleep in the general population. Neurophisol Clin 1996;26:30-9.
34. April RS. Observations on Parkinsonian tremor in all-night sleep. Neurology (New York) 1966;16:720-4,
35. Bergonzi P, Chiurulla C, Cianchetti, et al. Clinical pharmacology as an approach to the study of biochemical sleep mechanisms: the action of 1-dopa. Confin Neurol 1974;36:5-22.
36. Reynolds CF, Hoch CC, Stack J, Campbell D. The nature and management of sleep/wake disturbance in Alzheimer's dementia. Psychopharmacol Bull 1988;24:43-8.